S.1221 - A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.111th Congress (2009-2010)
|Sponsor:||Sen. Specter, Arlen [D-PA] (Introduced 06/09/2009)|
|Committees:||Senate - Finance|
|Latest Action:||Senate - 06/09/2009 Read twice and referred to the Committee on Finance. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: S.1221 — 111th Congress (2009-2010)All Information (Except Text)
Introduced in Senate (06/09/2009)
Amends title XVIII (Medicare) of the Social Security Act with respect to the use of average sales price methodology for calculating payments for drugs and biologicals under Medicare part B (Supplementary Medical Insurance).
Excludes from the manufacturer's average sales price when calculating such payments any customary prompt pay discounts extended to wholesalers.